Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -163,422 | -118,006 | -81,269 | -30,739 | -230,495 |
| Depreciation Amortization | -2,856 | -2,267 | -2,046 | -1,159 | -5,101 |
| Income taxes - deferred | -2,942 | N/A | N/A | N/A | N/A |
| Accounts receivable | 715 | -543 | 370 | 2,177 | -927 |
| Accounts payable and accrued liabilities | -6,413 | 3,520 | 6,802 | -16,089 | 14,848 |
| Other Working Capital | -14,787 | -15,555 | -1,159 | -18,909 | 36,518 |
| Other Operating Activity | 23,574 | 7,642 | 4,185 | 20,957 | 87,621 |
| Operating Cash Flow | $-166,131 | $-125,209 | $-73,117 | $-43,762 | $-97,536 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -304,991 | -329,831 | -286,399 | N/A | N/A |
| PPE Investments | -4,367 | -1,528 | -589 | -529 | -4,032 |
| Investing Cash Flow | $-309,358 | $-331,359 | $-286,988 | $-529 | $-4,032 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,466 | 24,473 | 24,695 | N/A | N/A |
| Common Stock Issued | 133,592 | 131,998 | 131,433 | 5 | 209,697 |
| Other Financing Activity | -605 | -605 | 0 | 0 | 145,167 |
| Financing Cash Flow | $157,453 | $155,866 | $156,128 | $5 | $354,864 |
| Exchange Rate Effect | 1,672 | 708 | 922 | 3,852 | -3,471 |
| Beginning Cash Position | 339,681 | 339,681 | 339,681 | 339,681 | 89,856 |
| End Cash Position | 23,317 | 39,687 | 136,626 | 299,247 | 339,681 |
| Net Cash Flow | $-316,364 | $-299,994 | $-203,055 | $-40,434 | $249,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -166,131 | -125,209 | -73,117 | -43,762 | -97,536 |
| Capital Expenditure | -4,367 | -1,528 | -589 | -529 | -4,032 |
| Free Cash Flow | -170,498 | -126,737 | -73,706 | -44,291 | -101,568 |